(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(0.00%) $82.81
(0.73%) $1.665
(-0.40%) $2 329.00
(-0.48%) $27.22
(-0.43%) $911.90
(0.02%) $0.935
(0.09%) $10.99
(0.04%) $0.803
(0.00%) $92.32
Live Chart Being Loaded With Signals
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions...
Stats | |
---|---|
Today's Volume | 2.34M |
Average Volume | 4.22M |
Market Cap | 5.07B |
EPS | €0 ( 2024-02-28 ) |
Next earnings date | ( €0 ) 2024-05-14 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | 93.07 |
ATR14 | €0.00900 (0.11%) |
Volume Correlation
Grifols, S.A. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Grifols, S.A. Correlation - Currency/Commodity
Grifols, S.A. Financials
Annual | 2023 |
Revenue: | €6.59B |
Gross Profit: | €2.32B (35.24 %) |
EPS: | €0.0873 |
Q3 | 2023 |
Revenue: | €1.60B |
Gross Profit: | €631.83M (39.55 %) |
EPS: | €0.0878 |
Q2 | 2023 |
Revenue: | €1.66B |
Gross Profit: | €620.06M (37.28 %) |
EPS: | €0.0767 |
Q1 | 2023 |
Revenue: | €1.54B |
Gross Profit: | €561.01M (36.37 %) |
EPS: | €-0.0156 |
Financial Reports:
No articles found.
Grifols, S.A.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators